Is Hyperoxia in Early Pediatric Veno-veno Extracorporeal Life Support Associated with Mortality?

Background: Data is limited regarding the effects of supraphysiologic blood oxygen tension (hyperoxia) in patients requiring extracorporeal life support (ECLS). We sought to evaluate the association between hyperoxia and outcomes in pediatric patients requiring veno-venous (VV) ECLS. Methods: Retrospective single-center study at an academic children’s hospital that included all patients 0–18 years who required VV-ECLS between 01/2014–12/2019. Results: During the study period 110 VV-ECLS runs occurred in 110 patients. Using a receiver operating characteristic curve, a mean PaO2 of 122 mmHg in the first 48-hours of ECLS was determined to have the optimal discriminatory ability with regard to mortality (sensitivity 41% and specificity 86%). Of the VV-ECLS runs, 68 (61.8%) had PaO2 > 122 mmHg (hyperoxia group). The hyperoxia group tended to be older (105.4 vs 1.6 months, p=0.001), had higher rates of hemorrhagic complications (69.6% vs 25.3%, p=0.0001), and higher mortality rate (57.9% vs 19.5%, p=0.002). Adjusting for confounders, the hyperoxia group had higher odds of mortality (OR 7.97, 95% CI 1.72 – 36.86, p=0.0079). Conclusion: Children exposed to hyperoxia during the first 48-hours of VV-ECLS were 8 times more likely to die than those who were not after adjusting for confounders (age group, BSA, and indication for ECLS). Multicenter and prospective evaluation of this modifiable risk factor is imperative to improving the care of this high-risk cohort.